TE_22755
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | AluY |
|---|---|
| TE superfamily | Alu |
| TE class | SINE |
| Gene | ENSG00000284931, OR51B5, HBE1, ENSG00000239920, -, HBG2 |
| Class | Chimeric, Intergenic |
| Coding | Non-coding |
| Tumor-specific score | 210.77 |
| Counts of samples | TCGA_tumor:186; TCGA_normal:0; GTEx:0 |
| TSS | chr11(-):5424894 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_22755.21 | OR51B5 | Chimeric | Non-coding | Non-coding | chr11(-):5343609,5343629,5345773,5345899,5346262,5346353,5346876,5346910,5424429,5424895 |
| teRNA_22755.22 | OR51B5 | Chimeric | Non-coding | Non-coding | chr11(-):5304457,5304477,5345773,5345899,5346262,5346353,5346876,5346910,5424383,5424895 |
| teRNA_22755.23 | OR51B5 | Chimeric | Non-coding | Non-coding | chr11(-):5305657,5305677,5345773,5345899,5346262,5346353,5346876,5346910,5424383,5424895 |
| teRNA_22755.24 | OR51B5 | Chimeric | Non-coding | Non-coding | chr11(-):5341342,5341362,5345773,5345899,5346262,5346353,5346876,5346910,5424383,5424895 |
| teRNA_22755.25 | OR51B5 | Chimeric | Non-coding | Non-coding | chr11(-):5343609,5343629,5345773,5345899,5346262,5346353,5346876,5346910,5424383,5424895 |
| teRNA_22755.26 | ENSG00000239920, OR51B5 | Chimeric | Non-coding | Non-coding | chr11(-):5254494,5254514,5254637,5255165,5345773,5345899,5424383,5424895 |
| teRNA_22755.27 | ENSG00000239920, OR51B5 | Chimeric | Non-coding | Non-coding | chr11(-):5304457,5304477,5345773,5345899,5424383,5424895 |
| teRNA_22755.28 | ENSG00000239920, OR51B5 | Chimeric | Non-coding | Non-coding | chr11(-):5305657,5305677,5345773,5345899,5424383,5424895 |
| teRNA_22755.29 | ENSG00000239920, OR51B5 | Chimeric | Non-coding | Non-coding | chr11(-):5341342,5341362,5345773,5345899,5424383,5424895 |
| teRNA_22755.30 | ENSG00000239920, OR51B5 | Chimeric | Non-coding | Non-coding | chr11(-):5343609,5343629,5345773,5345899,5424383,5424895 |
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
